Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  calcitriol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-23 of 23 for your search:
Start Over
Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 05M1, P30CA060553, NU-0310-093, SPRI-NU-05M1, NCT00301067
Phase I/II Calcitriol in Lung Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: UMCC 2008.042, HUM 21242, NCT00794547
Phase II Chemoprevention Study of Vitamin D3 and Calcium for Colorectal Cancer (Summary Last Modified 01/98)
Phase: Phase II
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: CPMC-IRB-6850, NCI-P97-0109
Phase II Study of Calcitriol in Patients with Hormone-Resistant Prostate Cancer (Summary Last Modified 10/93)
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: PCI-9304, NCI-V93-0286
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000270758, RPCI-RP-0203, PCI-00-034, NCT00054522
Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
Phase: Phase II
Type: Treatment
Status: Completed
Age: No age specified
Sponsor: Other
Protocol IDs: UPCI 01-020, FD-R-002025-01, NCT00030069
A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer
Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 011-017, NCT00536770
Calcitriol, Physical Activity, and Bone Health in Cancer Survivors
Phase: Phase II
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: RSRB00025478, NCT00904033
Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000445077, OHSU-GIM-02007-L, OHSU-1104, NCT00238199
Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068720, OHSU-6218, OHSU-HOR-00059-L, NCI-G01-1963, NCT00017576
Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 100
Sponsor: NCI, Other
Protocol IDs: CDR0000441172, OHSU-8451, OHSU-VA-IRB-9451, NCT00182741
Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000067041, OHSU-5231, OCC-HOR-98068-L, NCI-V99-1542, NCT00004043
Effects of High Dose Calcitriol in Breast Cancer Patients
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 to 88
Sponsor: Other
Protocol IDs: 25741, NCT01293682
Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: MEC 10-2-088, NCT01358045
Phase I Study of High Dose Intermittent Calcitriol for Advanced Malignancies (Summary Last Modified 09/98)
Phase: Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: OHSU-4673, OCC-ONC-97079-L, NCI-V98-1381
Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 97-004, CDR0000068374, PCI-IRB-970532, NCI-G00-1885, PCI-97-004, NCT00008086
Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 98-019, CDR0000068411, PCI-IRB-980542, NCI-G00-1901, PCI-98019, NCT00009802
Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: PCI-99044, CDR0000068457, PCI-IRB-990606, NCT00010231
Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000365546, RPCI-RPC-0207, ZENECA-1839US/0295, NCT00084708
Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: I 33204, RPCI-I-33204, NCT00238225
Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 45 and over
Sponsor: Other
Protocol IDs: PROS0022, 97408, NCT00482157
Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 40 to 70
Sponsor: Other
Protocol IDs: FMUSPIBCCVD2009, CAPPesq 626/06, FAPESP 07/04799-2, IBCC 108/2006/07, CAPPesq 0018/09, NCT00926315
Start Over